Cargando…

Immunotherapy in lung cancer

Detalles Bibliográficos
Autor principal: Vansteenkiste, Johan F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761224/
https://www.ncbi.nlm.nih.gov/pubmed/29344409
http://dx.doi.org/10.1136/esmoopen-2017-000311
_version_ 1783291528122204160
author Vansteenkiste, Johan F
author_facet Vansteenkiste, Johan F
author_sort Vansteenkiste, Johan F
collection PubMed
description
format Online
Article
Text
id pubmed-5761224
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57612242018-01-17 Immunotherapy in lung cancer Vansteenkiste, Johan F ESMO Open Podcast BMJ Publishing Group 2018-01-09 /pmc/articles/PMC5761224/ /pubmed/29344409 http://dx.doi.org/10.1136/esmoopen-2017-000311 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Podcast
Vansteenkiste, Johan F
Immunotherapy in lung cancer
title Immunotherapy in lung cancer
title_full Immunotherapy in lung cancer
title_fullStr Immunotherapy in lung cancer
title_full_unstemmed Immunotherapy in lung cancer
title_short Immunotherapy in lung cancer
title_sort immunotherapy in lung cancer
topic Podcast
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761224/
https://www.ncbi.nlm.nih.gov/pubmed/29344409
http://dx.doi.org/10.1136/esmoopen-2017-000311
work_keys_str_mv AT vansteenkistejohanf immunotherapyinlungcancer